Listed

RenovoRx, Inc.

RNXTNasdaqCIK 1574094HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$909.0k, Q2 FY2026
Operating income−$3.3m, Q2 FY2026
Net income−$2.9m, Q2 FY2026
RenovoRx, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$knot reportednot reportednot reportednot reportednot reportednot reported197Revenue, Q1 FY2025, three months to 2025-03-31$197.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-14, accession 0001193125-26-224100.Report this figure422Revenue, Q2 FY2025, three months to 2025-06-30$422.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure266Revenue, Q3 FY2025, three months to 2025-09-30$266.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-13, accession 0001493152-25-022304.Report this figure238Revenue, Q4 FY2025, three months to 2025-12-31$238.0k. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-30, accession 0001193125-26-131928. Derived: 12-month figure less the 9-month figure.Report this figure563Revenue, Q1 FY2026, three months to 2026-03-31$563.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-14, accession 0001193125-26-224100.Report this figure909Revenue, Q2 FY2026, three months to 2026-06-30$909.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure
Cost of revenue$knot reportednot reportednot reportednot reportednot reportednot reported94.0Cost of revenue, Q1 FY2025, three months to 2025-03-31$94.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-14, accession 0001193125-26-224100.Report this figure152Cost of revenue, Q2 FY2025, three months to 2025-06-30$152.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure53.0Cost of revenue, Q3 FY2025, three months to 2025-09-30$53.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-13, accession 0001493152-25-022304.Report this figure28.0Cost of revenue, Q4 FY2025, three months to 2025-12-31$28.0k. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-03-30, accession 0001193125-26-131928. Derived: 12-month figure less the 9-month figure.Report this figure84.0Cost of revenue, Q1 FY2026, three months to 2026-03-31$84.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-14, accession 0001193125-26-224100.Report this figure143Cost of revenue, Q2 FY2026, three months to 2026-06-30$143.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure
Gross profit$knot reportednot reportednot reportednot reportednot reportednot reported103Gross profit, Q1 FY2025, three months to 2025-03-31$103.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-14, accession 0001193125-26-224100.Report this figure270Gross profit, Q2 FY2025, three months to 2025-06-30$270.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure213Gross profit, Q3 FY2025, three months to 2025-09-30$213.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-13, accession 0001493152-25-022304.Report this figure210Gross profit, Q4 FY2025, three months to 2025-12-31$210.0k. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-30, accession 0001193125-26-131928. Derived: 12-month figure less the 9-month figure.Report this figure479Gross profit, Q1 FY2026, three months to 2026-03-31$479.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-14, accession 0001193125-26-224100.Report this figure766Gross profit, Q2 FY2026, three months to 2026-06-30$766.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure
Research and development$k1,629Research and development, Q3 FY2023, three months to 2023-09-30$1.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-13, accession 0001493152-24-045137.Report this figure775Research and development, Q4 FY2023, three months to 2023-12-31$775.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-04-01, accession 0001641172-25-001932. Derived: 12-month figure less the 9-month figure.Report this figure1,257Research and development, Q1 FY2024, three months to 2024-03-31$1.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-15, accession 0001641172-25-010935.Report this figure1,542Research and development, Q2 FY2024, three months to 2024-06-30$1.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0001641172-25-024020.Report this figure1,650Research and development, Q3 FY2024, three months to 2024-09-30$1.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001493152-25-022304.Report this figure1,576Research and development, Q4 FY2024, three months to 2024-12-31$1.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-30, accession 0001193125-26-131928. Derived: 12-month figure less the 9-month figure.Report this figure1,642Research and development, Q1 FY2025, three months to 2025-03-31$1.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001193125-26-224100.Report this figure1,426Research and development, Q2 FY2025, three months to 2025-06-30$1.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure1,685Research and development, Q3 FY2025, three months to 2025-09-30$1.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001493152-25-022304.Report this figure1,501Research and development, Q4 FY2025, three months to 2025-12-31$1.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-30, accession 0001193125-26-131928. Derived: 12-month figure less the 9-month figure.Report this figure1,228Research and development, Q1 FY2026, three months to 2026-03-31$1.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001193125-26-224100.Report this figure1,200Research and development, Q2 FY2026, three months to 2026-06-30$1.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure
Selling, general and administrative$knot reportednot reported1,219Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$1.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-15, accession 0001641172-25-010935.Report this figure1,492Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$1.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-14, accession 0001641172-25-024020.Report this figure1,178Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$1.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-13, accession 0001493152-25-022304.Report this figure1,099Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$1.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-30, accession 0001193125-26-131928. Derived: 12-month figure less the 9-month figure.Report this figure1,571Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$1.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-14, accession 0001193125-26-224100.Report this figure1,522Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$1.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure1,728Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$1.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-13, accession 0001493152-25-022304.Report this figure2,231Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$2.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-30, accession 0001193125-26-131928. Derived: 12-month figure less the 9-month figure.Report this figure2,720Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$2.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-14, accession 0001193125-26-224100.Report this figure2,915Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$2.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure
Operating income$k(2,983)Operating income, Q3 FY2023, three months to 2023-09-30−$3.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-13, accession 0001493152-24-045137.Report this figure(1,777)Operating income, Q4 FY2023, three months to 2023-12-31−$1.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-04-01, accession 0001641172-25-001932. Derived: 12-month figure less the 9-month figure.Report this figure(2,476)Operating income, Q1 FY2024, three months to 2024-03-31−$2.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-15, accession 0001641172-25-010935.Report this figure(3,034)Operating income, Q2 FY2024, three months to 2024-06-30−$3.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0001641172-25-024020.Report this figure(2,828)Operating income, Q3 FY2024, three months to 2024-09-30−$2.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022304.Report this figure(2,632)Operating income, Q4 FY2024, three months to 2024-12-31−$2.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-30, accession 0001193125-26-131928. Derived: 12-month figure less the 9-month figure.Report this figure(3,110)Operating income, Q1 FY2025, three months to 2025-03-31−$3.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-224100.Report this figure(2,678)Operating income, Q2 FY2025, three months to 2025-06-30−$2.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure(3,200)Operating income, Q3 FY2025, three months to 2025-09-30−$3.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022304.Report this figure(3,522)Operating income, Q4 FY2025, three months to 2025-12-31−$3.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-30, accession 0001193125-26-131928. Derived: 12-month figure less the 9-month figure.Report this figure(3,469)Operating income, Q1 FY2026, three months to 2026-03-31−$3.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-224100.Report this figure(3,349)Operating income, Q2 FY2026, three months to 2026-06-30−$3.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure
Interest expense$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$knot reportednot reported0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-15, accession 0001641172-25-010935.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-14, accession 0001641172-25-024020. Derived: 6-month figure less the 3-month figure.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-13, accession 0001493152-25-022304. Derived: 9-month figure less the 6-month figure.Report this figurenot reported0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-14, accession 0001193125-26-224100.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-14, accession 0001641172-25-024020. Derived: 6-month figure less the 3-month figure.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-13, accession 0001493152-25-022304. Derived: 9-month figure less the 6-month figure.Report this figure2.0Income tax, Q4 FY2025, three months to 2025-12-31$2.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-30, accession 0001193125-26-131928. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-14, accession 0001193125-26-224100.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-13, accession 0001193125-26-349190. Derived: 6-month figure less the 3-month figure.Report this figure
Net income$k(1,421)Net income, Q3 FY2023, three months to 2023-09-30−$1.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-13, accession 0001493152-24-045137.Report this figure(3,227)Net income, Q4 FY2023, three months to 2023-12-31−$3.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-04-01, accession 0001641172-25-001932. Derived: 12-month figure less the 9-month figure.Report this figure(1,076)Net income, Q1 FY2024, three months to 2024-03-31−$1.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022304.Report this figure(2,389)Net income, Q2 FY2024, three months to 2024-06-30−$2.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022304.Report this figure(2,471)Net income, Q3 FY2024, three months to 2024-09-30−$2.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022304.Report this figure(2,878)Net income, Q4 FY2024, three months to 2024-12-31−$2.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-30, accession 0001193125-26-131928. Derived: 12-month figure less the 9-month figure.Report this figure(2,420)Net income, Q1 FY2025, three months to 2025-03-31−$2.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure(2,895)Net income, Q2 FY2025, three months to 2025-06-30−$2.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure(2,912)Net income, Q3 FY2025, three months to 2025-09-30−$2.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022304.Report this figure(2,941)Net income, Q4 FY2025, three months to 2025-12-31−$2.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-30, accession 0001193125-26-131928. Derived: 12-month figure less the 9-month figure.Report this figure(3,521)Net income, Q1 FY2026, three months to 2026-03-31−$3.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure(2,911)Net income, Q2 FY2026, three months to 2026-06-30−$2.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure
Diluted EPS$ per share(0.13)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-13, accession 0001493152-24-045137.Report this figurenot reported(0.07)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-15, accession 0001641172-25-010935.Report this figure(0.10)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0001641172-25-024020.Report this figure(0.10)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001493152-25-022304.Report this figurenot reported(0.08)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001193125-26-224100.Report this figure(0.08)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure(0.08)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001493152-25-022304.Report this figurenot reported(0.09)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001193125-26-224100.Report this figure(0.06)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure
Basic EPS$ per share(0.13)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-13, accession 0001493152-24-045137.Report this figurenot reported(0.07)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-15, accession 0001641172-25-010935.Report this figure(0.10)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0001641172-25-024020.Report this figure(0.10)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001493152-25-022304.Report this figurenot reported(0.08)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001193125-26-224100.Report this figure(0.08)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure(0.08)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001493152-25-022304.Report this figurenot reported(0.09)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001193125-26-224100.Report this figure(0.06)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure

Balance sheet

Cash and equivalents$9.5m, Q2 FY2026
Shareholders' equity$9.0m, Q2 FY2026
RenovoRx, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m3.2Cash and equivalents, Q3 FY2023, at 2023-09-30$3.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-13, accession 0001493152-23-040598.Report this figure1.2Cash and equivalents, FY2023, at 2023-12-31$1.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-04-01, accession 0001641172-25-001932.Report this figure4.4Cash and equivalents, Q1 FY2024, at 2024-03-31$4.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-10, accession 0001493152-24-018704.Report this figure11.7Cash and equivalents, Q2 FY2024, at 2024-06-30$11.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-13, accession 0001493152-24-031675.Report this figure9.6Cash and equivalents, Q3 FY2024, at 2024-09-30$9.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-13, accession 0001493152-24-045137.Report this figure7.2Cash and equivalents, FY2024, at 2024-12-31$7.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-30, accession 0001193125-26-131928.Report this figure14.6Cash and equivalents, Q1 FY2025, at 2025-03-31$14.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-15, accession 0001641172-25-010935.Report this figure12.3Cash and equivalents, Q2 FY2025, at 2025-06-30$12.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-14, accession 0001641172-25-024020.Report this figure10.0Cash and equivalents, Q3 FY2025, at 2025-09-30$10.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001493152-25-022304.Report this figure7.0Cash and equivalents, FY2025, at 2025-12-31$7.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure12.4Cash and equivalents, Q1 FY2026, at 2026-03-31$12.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001193125-26-224100.Report this figure9.5Cash and equivalents, Q2 FY2026, at 2026-06-30$9.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure
Current assets$mnot reported1.5Current assets, FY2023, at 2023-12-31$1.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-04-01, accession 0001641172-25-001932.Report this figurenot reportednot reportednot reported7.8Current assets, FY2024, at 2024-12-31$7.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-30, accession 0001193125-26-131928.Report this figure15.7Current assets, Q1 FY2025, at 2025-03-31$15.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-15, accession 0001641172-25-010935.Report this figure13.4Current assets, Q2 FY2025, at 2025-06-30$13.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0001641172-25-024020.Report this figure11.0Current assets, Q3 FY2025, at 2025-09-30$11.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-13, accession 0001493152-25-022304.Report this figure7.9Current assets, FY2025, at 2025-12-31$7.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure13.7Current assets, Q1 FY2026, at 2026-03-31$13.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-14, accession 0001193125-26-224100.Report this figure10.8Current assets, Q2 FY2026, at 2026-06-30$10.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure
Total assets$m3.5Total assets, Q3 FY2023, at 2023-09-30$3.5m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-13, accession 0001493152-23-040598.Report this figure1.5Total assets, FY2023, at 2023-12-31$1.5m. XBRL concept us-gaap:Assets. 10-K filed 2025-04-01, accession 0001641172-25-001932.Report this figure4.8Total assets, Q1 FY2024, at 2024-03-31$4.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-10, accession 0001493152-24-018704.Report this figure12.0Total assets, Q2 FY2024, at 2024-06-30$12.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-13, accession 0001493152-24-031675.Report this figure10.0Total assets, Q3 FY2024, at 2024-09-30$10.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-13, accession 0001493152-24-045137.Report this figure8.1Total assets, FY2024, at 2024-12-31$8.1m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-30, accession 0001193125-26-131928.Report this figure16.0Total assets, Q1 FY2025, at 2025-03-31$16.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-15, accession 0001641172-25-010935.Report this figure13.6Total assets, Q2 FY2025, at 2025-06-30$13.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0001641172-25-024020.Report this figure11.2Total assets, Q3 FY2025, at 2025-09-30$11.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-13, accession 0001493152-25-022304.Report this figure8.1Total assets, FY2025, at 2025-12-31$8.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure14.0Total assets, Q1 FY2026, at 2026-03-31$14.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-14, accession 0001193125-26-224100.Report this figure11.5Total assets, Q2 FY2026, at 2026-06-30$11.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure
Current liabilities$m1.6Current liabilities, Q3 FY2023, at 2023-09-30$1.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-13, accession 0001493152-23-040598.Report this figure1.2Current liabilities, FY2023, at 2023-12-31$1.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-04-01, accession 0001641172-25-001932.Report this figure1.1Current liabilities, Q1 FY2024, at 2024-03-31$1.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-10, accession 0001493152-24-018704.Report this figure1.3Current liabilities, Q2 FY2024, at 2024-06-30$1.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-13, accession 0001493152-24-031675.Report this figure1.8Current liabilities, Q3 FY2024, at 2024-09-30$1.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-13, accession 0001493152-24-045137.Report this figure1.9Current liabilities, FY2024, at 2024-12-31$1.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-30, accession 0001193125-26-131928.Report this figure1.7Current liabilities, Q1 FY2025, at 2025-03-31$1.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-15, accession 0001641172-25-010935.Report this figure1.6Current liabilities, Q2 FY2025, at 2025-06-30$1.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0001641172-25-024020.Report this figure1.9Current liabilities, Q3 FY2025, at 2025-09-30$1.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-13, accession 0001493152-25-022304.Report this figure2.0Current liabilities, FY2025, at 2025-12-31$2.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure1.9Current liabilities, Q1 FY2026, at 2026-03-31$1.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-14, accession 0001193125-26-224100.Report this figure1.9Current liabilities, Q2 FY2026, at 2026-06-30$1.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure
Total liabilities$m3.5Total liabilities, Q3 FY2023, at 2023-09-30$3.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-13, accession 0001493152-23-040598.Report this figure4.5Total liabilities, FY2023, at 2023-12-31$4.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-04-01, accession 0001641172-25-001932.Report this figure3.0Total liabilities, Q1 FY2024, at 2024-03-31$3.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-10, accession 0001493152-24-018704.Report this figure2.7Total liabilities, Q2 FY2024, at 2024-06-30$2.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-13, accession 0001493152-24-031675.Report this figure3.0Total liabilities, Q3 FY2024, at 2024-09-30$3.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-13, accession 0001493152-24-045137.Report this figure3.6Total liabilities, FY2024, at 2024-12-31$3.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-30, accession 0001193125-26-131928.Report this figure2.9Total liabilities, Q1 FY2025, at 2025-03-31$2.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-15, accession 0001641172-25-010935.Report this figure3.0Total liabilities, Q2 FY2025, at 2025-06-30$3.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0001641172-25-024020.Report this figure3.1Total liabilities, Q3 FY2025, at 2025-09-30$3.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-13, accession 0001493152-25-022304.Report this figure2.7Total liabilities, FY2025, at 2025-12-31$2.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure2.7Total liabilities, Q1 FY2026, at 2026-03-31$2.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-14, accession 0001193125-26-224100.Report this figure2.5Total liabilities, Q2 FY2026, at 2026-06-30$2.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure
Shareholders' equity$m0.0Shareholders' equity, Q3 FY2023, at 2023-09-30$6.0k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-13, accession 0001493152-24-045137.Report this figure3.0Shareholders' equity, FY2023, at 2023-12-31$3.0m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-30, accession 0001193125-26-131928.Report this figure1.8Shareholders' equity, Q1 FY2024, at 2024-03-31$1.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001493152-25-022304.Report this figure9.3Shareholders' equity, Q2 FY2024, at 2024-06-30$9.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001493152-25-022304.Report this figure7.1Shareholders' equity, Q3 FY2024, at 2024-09-30$7.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001493152-25-022304.Report this figure4.5Shareholders' equity, FY2024, at 2024-12-31$4.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure13.2Shareholders' equity, Q1 FY2025, at 2025-03-31$13.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure10.6Shareholders' equity, Q2 FY2025, at 2025-06-30$10.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure8.1Shareholders' equity, Q3 FY2025, at 2025-09-30$8.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001493152-25-022304.Report this figure5.4Shareholders' equity, FY2025, at 2025-12-31$5.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure11.3Shareholders' equity, Q1 FY2026, at 2026-03-31$11.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure9.0Shareholders' equity, Q2 FY2026, at 2026-06-30$9.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure

Cash flow

Operating cash flow−$2.9m, Q2 FY2026
Capital expenditure$71.0k, Q2 FY2026
RenovoRx, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k(2,728)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$2.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-13, accession 0001493152-24-045137. Derived: 9-month figure less the 6-month figure.Report this figure(2,053)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$2.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-04-01, accession 0001641172-25-001932. Derived: 12-month figure less the 9-month figure.Report this figure(2,204)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$2.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-15, accession 0001641172-25-010935.Report this figure(2,297)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$2.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0001641172-25-024020. Derived: 6-month figure less the 3-month figure.Report this figure(2,194)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$2.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001493152-25-022304. Derived: 9-month figure less the 6-month figure.Report this figure(2,430)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$2.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-30, accession 0001193125-26-131928. Derived: 12-month figure less the 9-month figure.Report this figure(3,381)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$3.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001193125-26-224100.Report this figure(2,302)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$2.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-349190. Derived: 6-month figure less the 3-month figure.Report this figure(2,270)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$2.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001493152-25-022304. Derived: 9-month figure less the 6-month figure.Report this figure(3,020)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$3.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-30, accession 0001193125-26-131928. Derived: 12-month figure less the 9-month figure.Report this figure(3,709)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$3.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001193125-26-224100.Report this figure(2,867)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$2.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-349190. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$knot reportednot reportednot reportednot reportednot reportednot reported2.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$2.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001193125-26-224100.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001193125-26-349190. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001493152-25-022304. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-30, accession 0001193125-26-131928. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001193125-26-224100.Report this figure71.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$71.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001193125-26-349190. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)47.30m, Q2 FY2026
RenovoRx, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares9.1Diluted shares (weighted), Q3 FY2022, three months to 2022-09-309,067,509 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-13, accession 0001493152-23-040598.Report this figure9.1Diluted shares (weighted), Q1 FY2023, three months to 2023-03-319,089,989 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-10, accession 0001493152-24-018704.Report this figure10.7Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3010,655,155 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-13, accession 0001493152-24-031675.Report this figure10.7Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3010,693,080 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-13, accession 0001493152-24-045137.Report this figure14.9Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3114,947,500 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-15, accession 0001641172-25-010935.Report this figure24.0Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3024,049,113 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-14, accession 0001641172-25-024020.Report this figure24.9Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3024,940,746 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001493152-25-022304.Report this figure31.4Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3131,395,888 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001193125-26-224100.Report this figure36.6Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3036,576,567 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure36.6Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3036,646,278 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001493152-25-022304.Report this figure38.0Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3138,032,421 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001193125-26-224100.Report this figure47.3Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3047,298,148 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure

Shares outstanding: 45.13mShares outstanding, period not labelled, at 2026-08-0745,129,508 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-349190.Report this figure at Aug 7, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. Listed shows no prices and gives no investment advice.